查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1974927

2026-2034年全球早產及胎膜早破（PROM）檢測市場規模、佔有率、趨勢及成長分析報告

Global Preterm Birth And PROM Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 123 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計早產和胎膜早破 (PROM) 檢測的市場規模將從 2025 年的 23.6 億美元成長到 2034 年的 50.6 億美元，2026 年至 2034 年的複合年成長率為 8.86%。

隨著早期發現胎膜早破（PROM）和早產風險成為孕產婦保健的重中之重，全球早產和胎膜早破檢測市場正在成長。這些情況會顯著增加新生兒發病率和醫療保健成本。能夠識別生物標記、感染標記或胎膜變化的診斷測試有助於臨床醫生更早進行干預，從而改善母嬰結果。

全球出生率上升和新興市場產前保健基礎設施的不斷完善，推動了對可靠檢測套組的需求。醫療機構正在將先進的篩檢通訊協定納入常規產前檢查。醫療服務的可近性提高和公眾意識的增強，促使更多女性及時接受產前檢查。

生物技術的進步提高了檢測的準確性和速度，因此未來前景光明。就地檢驗和非侵入性檢測技術的開發將進一步擴大其應用範圍。與遠端醫療服務的整合有望改善遠距孕產婦監測。持續投入研發和臨床檢驗將維持市場成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球早產和胎膜早破（PROM）檢測市場：依檢測類型分類

  • 市場分析、洞察與預測
  • 骨盆腔檢查
  • 超音波檢查
  • 生化標記
  • 子宮監測
  • 尼他定試驗
  • 蕨狀結晶試驗
  • 池化方法
  • PAMG-1免疫檢測
  • IGFBP檢測
  • 胎兒纖維黏附蛋白（fFn）
  • 其他

第5章 全球早產和胎膜早破 (PROM) 檢測市場：按最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 診斷檢查室
  • 門診部
  • 研究機構
  • 其他

第6章 全球早產和胎膜早破 (PROM) 檢測市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Qiagen NV
    • Hologic Inc
    • Cooper Surgical Inc
    • Abbott
    • Medixbiochemica
    • Sera Prognostics
    • Clinical Innovations LLC
    • Biosynex
    • NX Prenatal Inc
    • IQ Products
簡介目錄
Product Code: VMR11211146

The Preterm Birth And PROM Testing Market size is expected to reach USD 5.06 Billion in 2034 from USD 2.36 Billion (2025) growing at a CAGR of 8.86% during 2026-2034.

The Global Preterm Birth and PROM Testing Market is growing as maternal healthcare prioritizes early detection of premature rupture of membranes (PROM) and preterm labor risk. These conditions contribute significantly to neonatal morbidity and healthcare costs. Diagnostic tests that identify biomarkers, infection markers, or membrane changes help clinicians intervene earlier to improve maternal and fetal outcomes.

Rising global birth rates and expanding prenatal care infrastructure in emerging markets increase demand for reliable testing kits. Healthcare providers are adopting advanced screening protocols as part of routine prenatal evaluations. Improved accessibility and awareness are encouraging women to seek timely prenatal assessments.

Future prospects look positive as biotechnology advances refine test accuracy and speed. Development of point-of-care and noninvasive testing options will broaden adoption. Integration with telehealth services could improve remote maternal monitoring. Continued investment into research and clinical validation will sustain market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

  • Pelvic Exam
  • Ultrasound
  • Biochemical Markers
  • Uterine Monitoring
  • Nitazine Test
  • Ferning Test
  • Pooling
  • Pamg-1 Immunoassay
  • IGFBP Test
  • Fetal Fibronectin (fFn)
  • Others

By End User

  • Hospitals
  • Diagnostics Laboratories
  • Outpatient Clinics
  • Research Centers
  • Others

COMPANIES PROFILED

  • Qiagen NV, Hologic Inc, Cooper Surgical Inc, Abbott, Medixbiochemica, Sera prognostics, Clinical Innovations LLC, Biosynex, NX Prenatal Inc, IQ Products
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRETERM BIRTH AND PROM TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Type
  • 4.2. Pelvic Exam Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Biochemical Markers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Uterine Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Nitazine Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Ferning Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Pooling Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Pamg-1 Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.10. IGFBP Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.11. Fetal Fibronectin (fFn) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.12. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRETERM BIRTH AND PROM TESTING MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Outpatient Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRETERM BIRTH AND PROM TESTING MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Test Type
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Test Type
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Test Type
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Test Type
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Test Type
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PRETERM BIRTH AND PROM TESTING INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Qiagen N.V
    • 8.2.2 Hologic Inc
    • 8.2.3 Cooper Surgical Inc
    • 8.2.4 Abbott
    • 8.2.5 Medixbiochemica
    • 8.2.6 Sera Prognostics
    • 8.2.7 Clinical Innovations LLC
    • 8.2.8 Biosynex
    • 8.2.9 NX Prenatal Inc
    • 8.2.10 IQ Products